Clinical Trial Update: Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients

View source ↗

Summary

Completed clinical trial evaluating how Qiliqiangxin Capsule regulates immunological cytokines in patients with dilated cardiomyopathy and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure

Drugs mentioned

• Qiliqiangxin Capsule

Snippet

Sponsor: Harbin Medical University | Conditions: Congestive Heart Failure | Status: COMPLETED